STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,700 shares, an increase of 183.3% from the February 13th total of 600 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 6,200 shares, the days-to-cover ratio is presently 0.3 days.
Wall Street Analyst Weigh In
Separately, Maxim Group assumed coverage on STRATA Skin Sciences in a report on Thursday, February 27th. They set a “buy” rating and a $6.00 price target for the company.
Get Our Latest Stock Analysis on SSKN
STRATA Skin Sciences Stock Down 1.4 %
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
See Also
- Five stocks we like better than STRATA Skin Sciences
- Election Stocks: How Elections Affect the Stock Market
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Canadian Penny Stocks: Can They Make You Rich?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.